Four historically Black medical schools received a combined $600 million from Bloomberg Philanthropies in one of the largest single investments in Black medical education in U.S. history. The announcement, made in August 2024 C.E., will more than double the endowments of three of the four recipient institutions and fund a new generation of Black physicians at a moment when health disparities remain a defining challenge in American life.
At a glance
- HBCU medical school funding: Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine each receive $175 million, while Charles R. Drew University of Medicine and Science receives $75 million.
- Endowment growth: The gifts will more than double the endowments of three of the four schools, strengthening their ability to cover rising tuition costs, expand research, and grow class sizes.
- New Orleans expansion: An additional $5 million will support a new medical school being built by Xavier University of Louisiana and Ochsner Health, extending the investment to a fifth historically Black institution.
Why this gift is different
Bloomberg Philanthropies has supported these four schools before. In 2020 C.E., the organization gave a combined $100 million — then the largest philanthropic gift from a single donor to historically Black medical institutions — which helped reduce the student debt of nearly 1,000 future Black doctors. A follow-up gift of $6 million in 2021 C.E. helped the schools expand COVID-19 vaccine access in underserved communities.
The 2024 C.E. donation is six times larger than that 2020 gift. It comes through Bloomberg Philanthropies’ Greenwood Initiative, which focuses on racial wealth equity and addressing systemic underinvestment in Black institutions.
What makes this moment significant is not just the dollar amount. Endowment funding is long-term, flexible capital — it allows institutions to plan decades ahead, recruit faculty, modernize facilities, and offer scholarships without depending on tuition revenue or short-term grants. For schools that have historically operated with far fewer resources than predominantly white medical institutions, a doubled endowment changes the structural equation.
The case for Black medical schools
Historically Black medical schools train a disproportionately large share of Black physicians in the United States. Research from the Association of American Medical Colleges has consistently shown that Black doctors are more likely to practice in underserved communities, more likely to treat Black patients, and associated with better health outcomes for those patients. Yet Black Americans remain significantly underrepresented in medicine — making up roughly 13% of the U.S. population but less than 6% of practicing physicians.
Howard University, Meharry, Morehouse, and Charles R. Drew were each founded in the aftermath of a medical establishment that systematically excluded Black students. The 1910 Flexner Report, a foundational document in American medical education, recommended closing most Black medical schools — a recommendation that was largely followed, reducing dozens of Black medical institutions to a handful. The schools receiving this funding are, in many ways, survivors of that era, and their continued existence has helped sustain Black medical education across more than a century.
What the money will do
Howard University President Ben Vinson III described the donation as “transformational” — not just for training health professionals, but for its effect on “intergenerational wealth and health” for medical students and the communities they will serve. Dr. James E.K. Hildreth, president of Meharry Medical College, called the investment “extraordinary” and said it underscored the importance of building a healthcare system that reflects the people it serves.
Bloomberg said the gift was intended to address both health disparities and underrepresentation in medicine simultaneously — a recognition that the two problems are connected. The Commonwealth Fund’s international health comparisons have repeatedly shown that the U.S. spends more on healthcare than any peer nation while achieving worse outcomes overall — with racial disparities among the sharpest and most persistent gaps.
The funding will also support Xavier University of Louisiana’s new medical school, developed in partnership with Ochsner Health. Xavier, a historically Black Catholic university in New Orleans, has long been one of the nation’s leading producers of Black students who go on to earn medical degrees. The new school aims to increase the pipeline of physicians serving Louisiana, a state with some of the worst health outcomes in the country.
A step forward with distance still to cover
Private philanthropy, however significant, cannot substitute for sustained public investment. The resource gap between historically Black medical schools and their wealthiest peers — schools like Harvard Medical School, which holds a multi-billion-dollar endowment — remains enormous even after these gifts. And the structural factors driving health disparities, from insurance coverage to environmental conditions to poverty, fall far outside any single donor’s reach.
Still, investments of this scale create real and lasting change at the institutional level. Decades of research show that workforce diversity in medicine improves care — particularly for communities that have historically been undertreated or mistreated by the medical system. Training more Black doctors is one of the clearest evidence-based levers available for reducing that gap.
For the students who will train at these schools, the scholarships, reduced debt, and expanded facilities made possible by this funding could determine not only their careers, but the health trajectories of the communities they serve.
Read more
For more on this story, see: The Guardian
For more from Good News for Humankind, see:
- Alzheimer’s risk cut in half by drug in landmark prevention trial
- Indigenous land rights recognized ahead of COP30 — 160 million hectares
- The Good News for Humankind archive on global health
About this article
- 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
- 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
- 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
- ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.
More Good News
-
Global suicide rate has dropped nearly 40% since the 1990s
Global suicide rates have dropped nearly 40% since the early 1990s, falling from roughly 15 deaths per 100,000 people to around nine — one of modern public health’s most significant and underreported victories. This decline was driven by expanded mental health services, crisis intervention programs, and proven strategies like restricting access to lethal means. The progress spans dozens of countries, with especially sharp declines in East Asia and Europe. Critically, this trend demonstrates that suicide is preventable at a population level — making the case for sustained investment in mental health infrastructure worldwide.
-
Rhinos return to Uganda’s wild after 43 years of absence
Uganda rhino reintroduction marks a historic milestone: wild rhinoceroses are roaming Ugandan soil for the first time in over 40 years. In 2026, rhinos bred at Ziwa Rhino Sanctuary were released into Kidepo Valley National Park, ending an absence caused entirely by poaching and political collapse during the Idi Amin era. The release represents decades of careful breeding, conservation funding, and community engagement. For local communities, conservationists, and a watching world, it proves that deliberate, sustained human effort can reverse even the most painful wildlife losses.
-
UK cancer death rates reach their lowest level ever recorded
Cancer death rates in the United Kingdom have fallen to the lowest level ever recorded, according to Cancer Research UK data published in 2026. Age-standardized mortality rates have dropped by more than 25% over the past two decades, driven by advances in lung, bowel, and breast cancer treatment and diagnosis. Expanded NHS screening programs, immunotherapy, and targeted drug therapies are credited as key factors behind the sustained decline. The achievement represents generations of compounding progress across research, clinical care, and public health, though significant inequalities in cancer survival persist across socioeconomic and geographic lines.
